Tirzepatide, a novel medication, is generating excitement as a potential treatment for individuals facing diabetes of type 2. Unlike common diabetes drugs , it functions through a innovative mechanism, targeting both GLP-1 and the GIP hormone receptors. Clinical data have demonstrated that tirzep